3.
热化组(TP化疗联合热疗)与单独化疗组(TP化疗)疗效比较的meta分析
Meta analysis of efficacy and safety for patients with NSCLC treated with TP Thermo-Chemotherapy and TP Chemotherapy alone
| Outcome | Included studies | (TP) TCT | (TP) CT | Heterogeneity | Statistical method | Result of meta-analysis | ||||||
| n | N | n | N | I2 | P | OR (95%CI) | P | |||||
| TP: paclitaxel and cisplatin. | ||||||||||||
| Total effective rate | 8[5-9, 12, 13, 15] | 137 | 245 | 79 | 244 | 0 | 0.93 | OR (M-H, Fixed, 95%CI) | 2.74 (1.88-4.00) | < 0.000, 01 | ||
| Improving rate of life quality | 5[5-8, 12] | 102 | 146 | 52 | 142 | 0 | 0.95 | OR (M-H, Fixed, 95%CI) | 4.15 (2.52-6.85) | < 0.000, 01 | ||
| Myelosuppression | 4[8, 9, 13, 15] | 77 | 129 | 83 | 132 | 0 | 0.70 | OR (M-H, Fixed, 95%CI) | 0.88 (0.53-1.47) | 0.63 | ||
| Gastrointestinal reaction | 3[8, 13, 15] | 65 | 79 | 68 | 82 | 0 | 0.84 | OR (M-H, Fixed, 95%CI) | 0.98 (0.42-2.29) | 0.96 | ||
| Diarrhoea | 3[8, 13, 15] | 21 | 79 | 20 | 82 | 0 | 0.82 | OR (M-H, Fixed, 95%CI) | 1.13 (0.56-2.32) | 0.73 | ||
| Neurotoxicity | 3[8, 13, 15] | 41 | 79 | 41 | 82 | 0 | 0.86 | OR (M-H, Fixed, 95%CI) | 1.14 (0.57-2.31) | 0.71 | ||